This inventor holds 1 USPTO granted patent. Top assignee: Yung Shin Pharmaceutical Ind. Co., Ltd.. Active years: 2005.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2005
Title: The Innovative Contributions of Ma Wei Yong
Introduction
Ma Wei Yong is a notable inventor based in Shanghai, China. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative work on fused tri-heterocyclic compounds. His expertise and dedication to research have led to the development of valuable compounds that have potential applications in various medical fields.
Latest Patents
Ma Wei Yong holds a patent for 9H-imidazo[1,2-a]purin-9-one compounds. This patent includes a detailed description of fused tri-heterocyclic compounds of the formula: Ris H or alkyl; Ris H, alkyl, alkenyl, aryl, heteroaryl, cyclyl, or heterocyclyl; Rand R, independently, is H, alkyl, alkenyl, aryl, heteroaryl, cyclyl, heterocyclyl, or (CRR)X(CRR)Y. The patent outlines various configurations and chemical properties that highlight the versatility and potential of these compounds in pharmaceutical applications. Ma Wei Yong has 1 patent to his name, showcasing his innovative approach to drug development.
Career Highlights
Ma Wei Yong is currently employed at Yung Shin Pharmaceutical Ind. Co., Ltd. His role at the company allows him to collaborate with other talented professionals in the field. His work has been instrumental in advancing the company's research initiatives and product development.
Collaborations
Some of Ma Wei Yong's coworkers include Fang Yu Lee and Fang Chen Lee. Their collaborative efforts contribute to a dynamic research environment that fosters innovation and creativity in pharmaceutical development.
Conclusion
Ma Wei Yong's contributions to the field of pharmaceuticals through his innovative patents and collaborative work exemplify the impact of dedicated inventors in advancing medical science. His ongoing research continues to pave the way for new therapeutic solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile